Rasagiline Mesylate is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Alvogen, Inc.. The primary component is Rasagiline Mesylate.
Product ID | 47781-138_26c7f84d-9c39-07c8-7bb5-49ebeadd7215 |
NDC | 47781-138 |
Product Type | Human Prescription Drug |
Proprietary Name | Rasagiline Mesylate |
Generic Name | Rasagiline Mesylate |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2016-12-19 |
Marketing End Date | 2020-09-01 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA201970 |
Labeler Name | Alvogen, Inc. |
Substance Name | RASAGILINE MESYLATE |
Active Ingredient Strength | 1 mg/1 |
Pharm Classes | Monoamine Oxidase Inhibitor [EPC],Monoamine Oxidase Inhibitors [MoA] |
NDC Exclude Flag | N |
Marketing Start Date | 2016-12-19 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA201970 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2016-12-19 |
Marketing End Date | 2020-09-01 |
Ingredient | Strength |
---|---|
RASAGILINE MESYLATE | .5 mg/1 |
SPL SET ID: | 92203c9a-3116-7d09-2492-be581ab6d08a |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0378-1270 | Rasagiline Mesylate | rasagiline mesylate |
0378-1271 | Rasagiline Mesylate | rasagiline mesylate |
14445-104 | Rasagiline Mesylate | Rasagiline Mesylate |
14445-105 | Rasagiline Mesylate | Rasagiline Mesylate |
23155-746 | Rasagiline Mesylate | Rasagiline Mesylate |
23155-747 | Rasagiline Mesylate | Rasagiline Mesylate |
47781-138 | Rasagiline Mesylate | Rasagiline Mesylate |
47781-139 | Rasagiline Mesylate | Rasagiline Mesylate |
43353-015 | Azilect | Rasagiline Mesylate |
68546-142 | Azilect | Rasagiline mesylate |
68546-229 | Azilect | Rasagiline mesylate |